Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
PHRRF
Stock Latest News
Company Announcements
PharmaTher’s Ketamine Drug Review Extended by FDA
4d ago
Premium
The Fly
PharmaTher says FDA extends review period for ketamine
4d ago
Premium
Company Announcements
PharmaTher Launches KetaVault™ to Propel Ketamine Innovation
6d ago
Premium
The Fly
PharmaTher unveils KetaVault portal
6d ago
Premium
Company Announcements
PharmaTher Receives FDA Approval Goal Date for Ketamine
2M ago
Premium
The Fly
PharmaTher receives FDA approval goal date for ketamine
2M ago
Premium
Company Announcements
PharmaTher Resubmits FDA Application for Ketamine, Aiming for Q2-2025 Approval
3M ago
Premium
Company Announcements
PharmaTher Advances Towards FDA Approval for Ketamine with Resubmission Plan
3M ago
Premium
The Fly
PharmaTher expects to submit minor amendment to CRL by end of February
3M ago
Premium
Company Announcements
PharmaTher Eyes FDA Approval and Future Growth in Ketamine Market
4M ago
Premium
The Fly
PharmaTher ‘on track’ to submit responses to FDA in February
4M ago
Premium
Company Announcements
PharmaTher Updates on Ketamine Drug Application
6M ago
Premium
The Fly
PharmaTher initiates activities to address ‘minor deficiencies’ in ketamine NDA
6M ago
Premium
Company Announcements
PharmaTher Updates on FDA Ketamine Application
6M ago
Premium
The Fly
PharmaTher says FDA grants post-complete letter clarification meeting
6M ago
Premium
Company Announcements
PharmaTher Secures FDA Meeting for Ketamine Drug
6M ago
Premium
The Fly
PharmaTher granted post-CRL clarification meeting request by FDA
6M ago
Premium
Company Announcements
PharmaTher Faces FDA Setback for Ketamine Drug
7M ago
Premium
The Fly
PharmaTher receives CRL from FDA for ketamine ANDA
7M ago
Premium
Company Announcements
PharmaTher Closes in on FDA Ketamine Approval Date
9M ago
Premium
The Fly
PharmaTher receives GDUFA goal date of October 29 for ketamine NDA
9M ago
Premium
Company Announcements
PharmaTher’s Potential Breakthrough in Monkeypox Treatment
9M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
